Product Details
Product Name:
SXC 2023 |
CAS No.:
1695562-36-7 |
Purity:
99.65% |
Supply Ability:
10g |
Release date:
2024/11/16 |
Product Introduction
Bioactivity
名稱 | SXC 2023 |
描述 | SXC 2023 ((S)-2-acetamido-3-(4-methylbenzoylthio)propanoic acid) is a therapeutic prodrug of N-acetyl-L-cysteine for the treatment of CNS disorders and neurocognitive disorders, and can be used to treat glutamatergic dysfunction and psychiatric disorders in which oxidative stress plays a key role. |
存儲條件 | Shipping with blue ice. |
溶解度 | DMSO : 55 mg/mL (195.5 mM)
|
關鍵字 | SXC2023 | SXC-2023 | 2-acetamido-3-(4-methylbenzoylthio)propanoic acid | SXC 2023 |
相關庫 | 經(jīng)典已知活性庫 | 已知活性化合物庫 |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:64-65-3
$64.00 / 500mg
-
CAS:2109805-56-1
$53.00 / 1mg
-
CAS:20736-25-8
$51.00 / 25mg
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |
|
$700.00/100μg |
VIP3Y
|
TargetMol Chemicals Inc.
|
2024-10-23 |